| Apellido | KAWAZOE |
| Nombre | AKIHITO |
| ID | 5424867 |
"Su solicitud se enviará en seg. Por favor espere."
SUGERENCIAS
ÁREA DE TRABAJO
FIRMA SELECCIONADA COMO BASE
Kawazoe, Akihito Autor ID: 5424867 ver autor
Articulos ( 6 en total, se muestran 3 )
● Initial data from the phase 3 KEYNOTE-811 study of trastuzumab and chemotherapy with or without pembrolizumab for HER2-positive metastatic gastric or gastroesophageal junction (G/GEJ) cancer, 2021
● Pembrolizumab in HER2-Positive Gastric Cancer, 2024
● Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial, 2023
Afiliaciones ( 3 en total )
● National Cancer Center Hospital East
● Natl Canc Ctr Hosp East
● Natl Canc Hosp East
FIRMAS SELECCIONADAS PARA AGRUPAR